View the PDF

Includes: Nanostics research update, 2026 Pathfinders Award, More men living longer with incurable prostate cancer report finds, VIR-5500 Receives FDA Fast Track Designation for Late-Line Metastatic CRPC, Targeted radioactive therapy may help delay spread of recurrent prostate cancer, PSMA PET/CT-targeted biopsy improves detection of clinically significant prostate cancer, Decision Regret and Patient Satisfaction after TURP and Rezūm for Benign Prostatic Obstruction, Genomic cancer driver study reveals new clues to why some prostate cancers become aggressive, and more.